Summit Trail Advisors »

Seres Therapeutics shares owned by Summit Trail Advisors

Quarter-by-quarter ownership of Seres Therapeutics (MCRB) shares owned by Summit Trail Advisors from 13F filings

Historical chart of Summit Trail Advisors investment in Seres Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Seres Therapeutics held by Summit Trail Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Seres Therapeutics by Summit Trail Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $7.7k 10k 0.77

More positions owned by Summit Trail Advisors

Wisdomtree Tr Floatng Rat Trea (USFR)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Scottsdale Fds Inter Term Treas (VGIT)
Ishares Tr Core Us Aggbd Et (AGG)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Broadcom (AVGO)
Invesco Exchange Traded Fd T Aerospace Defn (PPA)
Select Sector Spdr Tr Sbi Healthcare (XLV)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Apple (AAPL)
Expeditors International of Washington (EXPD)
Kraneshares Trust California Carb (KCCA)
Ishares Tr Rus 1000 Grw Etf (IWF)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)

View all positions for Summit Trail Advisors

Top funds holding Seres Therapeutics

Flagship Ventures Management
Vanguard Group
Hudson Bay Capital Management
Bank of America Corporation
Millennium Management
Point72 Asset Management
Tang Capital Management
Handelsbanken Fonder AB
Charles Schwab Investment Management
Goldman Sachs Group
Advisor Group Holdings
Hrt Financial
T. Rowe Price Associates
Two Sigma Investments
Lion Point Capital

View all funds holding Seres Therapeutics